BioSpace News Archive

Bio NC

Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference

Shattuck Labs, Inc. announced that company management will participate in the 6th Annual Evercore ISI HealthCONx Conference being held November 28-30, 2023.

November 14, 2023
·
1 min read
Biotech Bay

IgGenix Publishes New Data Supporting Further Development of Allergen-Specific Therapeutics for the Treatment of Peanut Allergy

IgGenix, Inc. published new data as part of an international collaboration on the role of human monoclonal IgE antibodies in peanut allergy.

November 14, 2023
·
3 min read
Biotech Beach

Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program

Regen BioPharma, Inc. has previously discussed initiation of its DuraCAR CAR T-cell therapeutic. This program is designed to create chimeric antigen T-cells that silence the gene for NR2F6.

November 14, 2023
·
2 min read
Biotech Beach

Amydis Receives $3.4 million NIH Commercialization Readiness Pilot Grant Award to Map Heterogeneity of Alzheimer’s Diseases in Human Clinical Trial Using Novel Retinal Tracer

Amydis Inc., a privately held clinical-stage company pioneering a platform of ocular tracers to enable imaging of disease biomarkers in the eye, announced that it has received a two-year Commercialization Readiness Pilot Program grant award of $3.4 million from The National Institutes of Health.

November 14, 2023
·
3 min read
Business

Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates

Galera Therapeutics, Inc. announced financial results for the third quarter ended September 30, 2023 and provided recent corporate updates.

November 14, 2023
·
11 min read
Business

Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update

Femasys Inc. today announced financial results for the third quarter ended September 30, 2023 and provided a corporate update.

November 14, 2023
·
16 min read
Business

Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Vincerx Pharma, Inc. (Nasdaq: VINC)(“Vincerx”), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today reported financial results for the third quarter ended September 30, 2023 and provided a corporate update.

November 14, 2023
·
14 min read
Business

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024

Renalytix plc today reported financial results for the fiscal first quarter ended September 30, 2023.

November 14, 2023
·
12 min read
Drug Development

BioXcel Therapeutics Aligns with FDA Recommendation for Phase 3 Trial for TRANQUILITY Program, Provides Update on Strategic Financing, and Reports Third Quarter 2023 Financial Results

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced alignment with the FDA’s recommendation for a Phase 3 trial in the TRANQUILITY program.

November 14, 2023
·
17 min read
Business

Evofem Biosciences Announces Financial Results for the Third Quarter of 2023

Evofem Biosciences, Inc. (OTCQB: EVFM) today announced financial results for the third quarter and nine months ended September 30, 2023.

November 14, 2023
·
8 min read